Complete remission of nephrotic syndrome secondary to amyloid a amyloidosis in patient with inactive Crohn's disease after treatment by infliximab.

We present a case of a 34-year-old female patient with CD treated by azathioprine with inactive disease for three years and who developed a nephrotic syndrome secondary to AA amyloidosis. The treatment by infliximab for one year leads to a complete remission of the nephrotic syndrome. In this case, this complication occurred while the patient was clinically well, with biological and endoscopic markers showing an inactive or only mildly active disease. Infliximab could be a useful tool for a successful treatment of amyloidosis secondary to CD. PMID: 29657220 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29657220?dopt=Abstract

Source: Saudi Journal of Kidney Diseases and Transplantation - March 1, 2018 Category: Urology & Nephrology Authors: Hassani K, Hamzi MA, El Kabbaj D Tags: Saudi J Kidney Dis Transpl Source Type: research